BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jayakumar AR, Norenberg MD. Hyperammonemia in Hepatic Encephalopathy. J Clin Exp Hepatol. 2018;8:272-280. [PMID: 30302044 DOI: 10.1016/j.jceh.2018.06.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Snehavardhan P, Lal BB, Sood V, Khanna R, Alam S. Efficacy and Safety of Sodium Benzoate in The Management of Hyperammonemia in Decompensated Chronic Liver Disease of the Childhood—A Double-blind Randomized Controlled Trial. Journal of Pediatric Gastroenterology & Nutrition 2020;70:165-70. [DOI: 10.1097/mpg.0000000000002521] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Regan JT, Mirczuk SM, Scudder CJ, Stacey E, Khan S, Worwood M, Powles T, Dennis-Beron JS, Ginley-Hidinger M, McGonnell IM, Volk HA, Strickland R, Tivers MS, Lawson C, Lipscomb VJ, Fowkes RC. Sensitivity of the Natriuretic Peptide/cGMP System to Hyperammonaemia in Rat C6 Glioma Cells and GPNT Brain Endothelial Cells. Cells 2021;10:398. [PMID: 33672024 DOI: 10.3390/cells10020398] [Reference Citation Analysis]
3 Kreisel W, Lazaro A, Trebicka J, Grosse Perdekamp M, Schmitt-Graeff A, Deibert P. Cyclic GMP in Liver Cirrhosis-Role in Pathophysiology of Portal Hypertension and Therapeutic Implications. Int J Mol Sci 2021;22:10372. [PMID: 34638713 DOI: 10.3390/ijms221910372] [Reference Citation Analysis]
4 Campion D, Giovo I, Ponzo P, Saracco GM, Balzola F, Alessandria C. Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis. World J Hepatol 2019; 11(6): 489-512 [PMID: 31293718 DOI: 10.4254/wjh.v11.i6.489] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
5 Cheon SY, Jo D, Kim Y, Song J, Rai SN. Long Noncoding RNAs Regulate Hyperammonemia-Induced Neuronal Damage in Hepatic Encephalopathy. Oxidative Medicine and Cellular Longevity 2022;2022:1-13. [DOI: 10.1155/2022/7628522] [Reference Citation Analysis]
6 Bayat M, Khalili A, Bayat G, Akbari S, Yousefi Nejad A, Borhani Haghighi A, Haghani M. Effects of platelet-rich plasma on the memory impairment, apoptosis, and hippocampal synaptic plasticity in a rat model of hepatic encephalopathy. Brain Behav 2021;:e32447. [PMID: 34855284 DOI: 10.1002/brb3.2447] [Reference Citation Analysis]
7 Gelpi E, Rahimi J, Klotz S, Schmid S, Ricken G, Forcen-Vega S, Budka H, Kovacs GG. The autophagic marker p62 highlights Alzheimer type II astrocytes in metabolic/hepatic encephalopathy. Neuropathology 2020;40:358-66. [PMID: 32483828 DOI: 10.1111/neup.12660] [Reference Citation Analysis]
8 Mehtani R, Garg S, Kajal K, Soni SL, Premkumar M. Neurological monitoring and sedation protocols in the Liver Intensive Care Unit. Metab Brain Dis 2022. [PMID: 35460476 DOI: 10.1007/s11011-022-00986-7] [Reference Citation Analysis]
9 Wang Q, Guan K, Lv Y, Zhang Y, Yu Z, Kan Q. Disturbance of hepatocyte growth and metabolism in a hyperammonemia microenvironment. Arch Biochem Biophys 2021;716:109109. [PMID: 34932992 DOI: 10.1016/j.abb.2021.109109] [Reference Citation Analysis]
10 França MER, Peixoto CA. cGMP signaling pathway in hepatic encephalopathy neuroinflammation and cognition. Int Immunopharmacol 2020;79:106082. [PMID: 31869775 DOI: 10.1016/j.intimp.2019.106082] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Premkumar M, Dhiman RK. UPDATE IN HEPATIC ENCEPHALOPATHY - PART II. J Clin Exp Hepatol 2018;8:333-4. [PMID: 30568343 DOI: 10.1016/j.jceh.2018.11.001] [Reference Citation Analysis]
12 Brusilow WSA. Saul Brusilow: Understanding and treating diseases of ammonia toxicity. Anal Biochem 2022;636:114478. [PMID: 34808107 DOI: 10.1016/j.ab.2021.114478] [Reference Citation Analysis]
13 Hajipour S, Farbood Y, Dianat M, Rashno M, Khorsandi LS, Sarkaki A. Thymoquinone improves behavioral and biochemical deficits in hepatic encephalopathy induced by thioacetamide in rats. Neurosci Lett 2021;745:135617. [PMID: 33421492 DOI: 10.1016/j.neulet.2020.135617] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Espina S, Gonzalez-Irazabal Y, Sanz-Paris A, Lopez-Yus M, Garcia-Sobreviela MP, Del Moral-Bergos R, Garcia-Rodriguez B, Fuentes-Olmo J, Bernal-Monterde V, Arbones-Mainar JM. Amino Acid Profile in Malnourished Patients with Liver Cirrhosis and Its Modification with Oral Nutritional Supplements: Implications on Minimal Hepatic Encephalopathy. Nutrients 2021;13:3764. [PMID: 34836020 DOI: 10.3390/nu13113764] [Reference Citation Analysis]
15 Schindler P, Heinzow H, Trebicka J, Wildgruber M. Shunt-Induced Hepatic Encephalopathy in TIPS: Current Approaches and Clinical Challenges. J Clin Med 2020;9:E3784. [PMID: 33238576 DOI: 10.3390/jcm9113784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Chen Z, Ruan J, Li D, Wang M, Han Z, Qiu W, Wu G. The Role of Intestinal Bacteria and Gut-Brain Axis in Hepatic Encephalopathy. Front Cell Infect Microbiol 2020;10:595759. [PMID: 33553004 DOI: 10.3389/fcimb.2020.595759] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
17 Khalil HMA, Eliwa HA, El-Shiekh RA, Al-Mokaddem AK, Hassan M, Tawfek AM, El-Maadawy WH. Ashwagandha (Withania somnifera) root extract attenuates hepatic and cognitive deficits in thioacetamide-induced rat model of hepatic encephalopathy via induction of Nrf2/HO-1 and mitigation of NF-κB/MAPK signaling pathways. J Ethnopharmacol 2021;277:114141. [PMID: 33905819 DOI: 10.1016/j.jep.2021.114141] [Reference Citation Analysis]
18 Edgar JA, Molyneux RJ, Colegate SM. 1,2-Dehydropyrrolizidine Alkaloids: Their Potential as a Dietary Cause of Sporadic Motor Neuron Diseases. Chem Res Toxicol 2022. [PMID: 35238548 DOI: 10.1021/acs.chemrestox.1c00384] [Reference Citation Analysis]
19 Zhang S, Wang R, Zhao Y, Tareq FS, Sang S. Metabolic Interaction between Ammonia and Baicalein. Chem Res Toxicol 2020;33:2181-8. [PMID: 32618193 DOI: 10.1021/acs.chemrestox.0c00205] [Reference Citation Analysis]
20 Chen L, Tian Q, Zhang M, Chen D, Gao X, Yang H, Li H, Li C, Wen J, Li Y, Tian X, Chen P. CPS1 T1405N polymorphism, HDL cholesterol, homocysteine and renal function are risk factors of VPA induced hyperammonemia among epilepsy patients. Epilepsy Res 2019;154:139-43. [PMID: 31151073 DOI: 10.1016/j.eplepsyres.2019.05.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 López-Cervantes M, Quintanar-Stephano A, Alcauter-Solórzano S, Hernández-Pando R, Aguilar-Roblero R, Gasca-Martínez D, Ortíz JJ, Vázquez-Martínez O, Ximénez-Camilli C, Díaz-Muñoz M. Cerebellar spongiform degeneration is accompanied by metabolic, cellular, and motor disruption in male rats with portacaval anastomosis. J Neurosci Res 2021;99:2287-304. [PMID: 34061383 DOI: 10.1002/jnr.24853] [Reference Citation Analysis]
22 Cho I, Koo BN, Kam EH, Lee SK, Oh H, Kim SY. Bile duct ligation of C57BL/6 mice as a model of hepatic encephalopathy. Anesth Pain Med (Seoul) 2020;15:19-27. [PMID: 33329785 DOI: 10.17085/apm.2020.15.1.19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Limón ID, Angulo-Cruz I, Sánchez-Abdon L, Patricio-Martínez A. Disturbance of the Glutamate-Glutamine Cycle, Secondary to Hepatic Damage, Compromises Memory Function. Front Neurosci 2021;15:578922. [PMID: 33584185 DOI: 10.3389/fnins.2021.578922] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Pathania A, Rawat A, Dahiya SS, Dhanda S, Barnwal RP, Baishya B, Sandhir R. 1H NMR-Based Metabolic Signatures in the Liver and Brain in a Rat Model of Hepatic Encephalopathy. J Proteome Res 2020;19:3668-79. [PMID: 32660248 DOI: 10.1021/acs.jproteome.0c00165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Menozzi M, Gosse J, Talamonti M, Di Bernardini E, Quispe Cornejo A, Gustot T, Creteur J, Peluso L, Taccone FS. The use of automated pupillometry in critically ill cirrhotic patients with hepatic encephalopathy. J Crit Care 2021;62:176-82. [PMID: 33388562 DOI: 10.1016/j.jcrc.2020.12.013] [Reference Citation Analysis]
26 Yan J, Shen S, He Y, Li Z. TLR5 silencing reduced hyperammonaemia-induced liver injury by inhibiting oxidative stress and inflammation responses via inactivating NF-κB and MAPK signals. Chem Biol Interact 2019;299:102-10. [PMID: 30508503 DOI: 10.1016/j.cbi.2018.11.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
27 Zimmermann M, Reichert AS. Rapid metabolic and bioenergetic adaptations of astrocytes under hyperammonemia - a novel perspective on hepatic encephalopathy. Biol Chem 2021;402:1103-13. [PMID: 34331848 DOI: 10.1515/hsz-2021-0172] [Reference Citation Analysis]
28 El-Hagrassi AM, Osman AF, El-Naggar ME, Mowaad NA, Khalil S, Hamed MA. Phytochemical constituents and protective efficacy of Schefflera arboricola L. leaves extract against thioacetamide-induced hepatic encephalopathy in rats. Biomarkers 2022;:1-63. [PMID: 35234557 DOI: 10.1080/1354750X.2022.2048892] [Reference Citation Analysis]